Literature DB >> 17611973

Immunopathologic aspects of rheumatoid arthritis: who is the conductor and who plays the immunologic instrument?

Cornelia M Weyand1.   

Abstract

The inflammatory process of rheumatoid arthritis (RA) resembles a symphony orchestra playing a piece of music--not a song that anyone wants to hear, but a song nevertheless. Each cellular player has a distinct role, and all must coordinate in order to play their discordant "music" successfully. Rheumatoid synovitis consists of resident cells and invading immune cells that together arrange the inflammatory process in RA. There are 3 major types of synovitis that RA can comprise: germinal center synovitis, aggregate synovitis, and diffuse synovitis. Germinal centers are highly organized complex structures that are functionally competent. Aggregates are B cells and T cells arranged in defined follicles, yet they lack germinal center reactions. Diffuse synovitis is the least organized but can still cause significant damage. For each of these types of synovitis, the cellular players and their molecular instruments vary significantly. Differences in lymphoid microorganizations draw attention to the process of lymphoid organogenesis as a fundamental pathway of rheumatoid synovitis, a process that lends stability and sustainability to dysfunctional immune responses. This article will address how tissue-resident and invading cells, in particular T cells, B cells, dendritic cells, and synoviocytes, are brought together in different "symphonic" arrangements and how this process of lymphoid organization affects disease outcome and therapeutic options in RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611973

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  8 in total

1.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

2.  [Hand and wrist surgery].

Authors:  E Vögelin; P M Villiger
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

3.  Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.

Authors:  Natalie E Castellana; Krista McCutcheon; Victoria C Pham; Kristin Harden; Allen Nguyen; Judy Young; Camellia Adams; Kurt Schroeder; David Arnott; Vineet Bafna; Jane L Grogan; Jennie R Lill
Journal:  Proteomics       Date:  2011-01-05       Impact factor: 3.984

Review 4.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

Review 5.  Treating autoimmune disease by targeting CD8(+) T suppressor cells.

Authors:  Christine Konya; Jorg J Goronzy; Cornelia M Weyand
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

6.  A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; John A Skinner; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Res Ther       Date:  2012-01-31       Impact factor: 5.156

7.  Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.

Authors:  Brinda Emu; Diana Luca; Carolyn Offutt; Jane L Grogan; Bernadette Rojkovich; Marna B Williams; Meina T Tang; Jim Xiao; June H Lee; John C Davis
Journal:  Arthritis Res Ther       Date:  2012-01-08       Impact factor: 5.156

Review 8.  Monocytes, Macrophages, and Their Potential Niches in Synovial Joints - Therapeutic Targets in Post-Traumatic Osteoarthritis?

Authors:  Patrick Haubruck; Marlene Magalhaes Pinto; Babak Moradi; Christopher B Little; Rebecca Gentek
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.